BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 26, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

EnVivo preclinical data

In a transgenic mouse model of AD, daily oral EVP-0015962 significantly reduced the production of beta amyloid 42 as measured by plaque count, surface...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >